301 related articles for article (PubMed ID: 9380693)
21. Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta.
Feng XH; Lin X; Derynck R
EMBO J; 2000 Oct; 19(19):5178-93. PubMed ID: 11013220
[TBL] [Abstract][Full Text] [Related]
22. Synthetic triterpenoids enhance transforming growth factor beta/Smad signaling.
Suh N; Roberts AB; Birkey Reffey S; Miyazono K; Itoh S; ten Dijke P; Heiss EH; Place AE; Risingsong R; Williams CR; Honda T; Gribble GW; Sporn MB
Cancer Res; 2003 Mar; 63(6):1371-6. PubMed ID: 12649201
[TBL] [Abstract][Full Text] [Related]
23. A distinct nuclear localization signal in the N terminus of Smad 3 determines its ligand-induced nuclear translocation.
Xiao Z; Liu X; Henis YI; Lodish HF
Proc Natl Acad Sci U S A; 2000 Jul; 97(14):7853-8. PubMed ID: 10884415
[TBL] [Abstract][Full Text] [Related]
24. Receptor-associated Mad homologues synergize as effectors of the TGF-beta response.
Zhang Y; Feng X; We R; Derynck R
Nature; 1996 Sep; 383(6596):168-72. PubMed ID: 8774881
[TBL] [Abstract][Full Text] [Related]
25. Induction of apoptosis by Smad3 and down-regulation of Smad3 expression in response to TGF-beta in human normal lung epithelial cells.
Yanagisawa K; Osada H; Masuda A; Kondo M; Saito T; Yatabe Y; Takagi K; Takahashi T; Takahashi T
Oncogene; 1998 Oct; 17(13):1743-7. PubMed ID: 9796704
[TBL] [Abstract][Full Text] [Related]
26. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
[TBL] [Abstract][Full Text] [Related]
27. A single missense mutant of Smad3 inhibits activation of both Smad2 and Smad3, and has a dominant negative effect on TGF-beta signals.
Goto D; Yagi K; Inoue H; Iwamoto I; Kawabata M; Miyazono K; Kato M
FEBS Lett; 1998 Jul; 430(3):201-4. PubMed ID: 9688538
[TBL] [Abstract][Full Text] [Related]
28. Bone morphogenetic protein-7 inhibits proximal tubular epithelial cell Smad3 signaling via increased SnoN expression.
Luo DD; Phillips A; Fraser D
Am J Pathol; 2010 Mar; 176(3):1139-47. PubMed ID: 20093492
[TBL] [Abstract][Full Text] [Related]
29. Contribution of the constitutive and inducible degradation of Smad3 by the ubiquitin-proteasome pathway to transforming growth factor-beta signaling.
Inoue Y; Kitagawa M; Onozaki K; Hayashi H
J Interferon Cytokine Res; 2004 Jan; 24(1):43-54. PubMed ID: 14980084
[TBL] [Abstract][Full Text] [Related]
30. Constitutive phosphorylation and nuclear localization of Smad3 are correlated with increased collagen gene transcription in activated hepatic stellate cells.
Inagaki Y; Mamura M; Kanamaru Y; Greenwel P; Nemoto T; Takehara K; Ten Dijke P; Nakao A
J Cell Physiol; 2001 Apr; 187(1):117-23. PubMed ID: 11241356
[TBL] [Abstract][Full Text] [Related]
31. Transforming growth factor-beta1-dependent activation of Smad2/3 and up-regulation of PAI-1 expression is negatively regulated by Src in SKOV-3 human ovarian cancer cells.
Wakahara K; Kobayashi H; Yagyu T; Matsuzaki H; Kondo T; Kurita N; Sekino H; Inagaki K; Suzuki M; Kanayama N; Terao T
J Cell Biochem; 2004 Oct; 93(3):437-53. PubMed ID: 15372629
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of transforming growth factor-beta signaling by low molecular weight compounds interfering with ATP- or substrate-binding sites of the TGF beta type I receptor kinase.
Yakymovych I; Engström U; Grimsby S; Heldin CH; Souchelnytskyi S
Biochemistry; 2002 Sep; 41(36):11000-7. PubMed ID: 12206672
[TBL] [Abstract][Full Text] [Related]
33. Kinetic characterization of novel pyrazole TGF-beta receptor I kinase inhibitors and their blockade of the epithelial-mesenchymal transition.
Peng SB; Yan L; Xia X; Watkins SA; Brooks HB; Beight D; Herron DK; Jones ML; Lampe JW; McMillen WT; Mort N; Sawyer JS; Yingling JM
Biochemistry; 2005 Feb; 44(7):2293-304. PubMed ID: 15709742
[TBL] [Abstract][Full Text] [Related]
34. Smad3 and PKCdelta mediate TGF-beta1-induced collagen I expression in human mesangial cells.
Runyan CE; Schnaper HW; Poncelet AC
Am J Physiol Renal Physiol; 2003 Sep; 285(3):F413-22. PubMed ID: 12759229
[TBL] [Abstract][Full Text] [Related]
35. Effect of progesterone on Smad signaling and TGF-β/Smad-regulated genes in lung epithelial cells.
Kunzmann S; Ottensmeier B; Speer CP; Fehrholz M
PLoS One; 2018; 13(7):e0200661. PubMed ID: 30001393
[TBL] [Abstract][Full Text] [Related]
36. Unique and redundant roles of Smad3 in TGF-beta-mediated regulation of long bone development in organ culture.
Alvarez J; Serra R
Dev Dyn; 2004 Aug; 230(4):685-99. PubMed ID: 15254903
[TBL] [Abstract][Full Text] [Related]
37. Interaction between Smad anchor for receptor activation and Smad3 is not essential for TGF-beta/Smad3-mediated signaling.
Goto D; Nakajima H; Mori Y; Kurasawa K; Kitamura N; Iwamoto I
Biochem Biophys Res Commun; 2001 Mar; 281(5):1100-5. PubMed ID: 11243848
[TBL] [Abstract][Full Text] [Related]
38. Sp1 and Smad transcription factors co-operate to mediate TGF-beta-dependent activation of amyloid-beta precursor protein gene transcription.
Docagne F; Gabriel C; Lebeurrier N; Lesné S; Hommet Y; Plawinski L; Mackenzie ET; Vivien D
Biochem J; 2004 Oct; 383(Pt 2):393-9. PubMed ID: 15242331
[TBL] [Abstract][Full Text] [Related]
39. SnoN is a cell type-specific mediator of transforming growth factor-beta responses.
Sarker KP; Wilson SM; Bonni S
J Biol Chem; 2005 Apr; 280(13):13037-46. PubMed ID: 15677458
[TBL] [Abstract][Full Text] [Related]
40. Axin facilitates Smad3 activation in the transforming growth factor beta signaling pathway.
Furuhashi M; Yagi K; Yamamoto H; Furukawa Y; Shimada S; Nakamura Y; Kikuchi A; Miyazono K; Kato M
Mol Cell Biol; 2001 Aug; 21(15):5132-41. PubMed ID: 11438668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
